Security
BioCorRx Inc. Common Stock · BICX
BICXOTCCommon stockHistorical · closed Jan 22, 2019CIK 1443863Updated Nov 17, 2026
BICX price & chart
This listing closed Jan 22, 2019. Live provider charts are shown only for current listings.
Current security: BICX
About the company
BioCorRx Inc. (OTCQB: BICX) is an addiction treatment solutions company offering a unique approach to the treatment of substance use and other related disorders. Beat Addiction Recovery is a substance use disorder recovery program that typically includes BioCorRx's proprietary Cognitive Behavioral Therapy (CBT) modules along with peer support via mobile app along with medication prescribed by an independent treating physician under their discretion. The UnCraveRx® Weight Loss Program is also a medication-assisted weight loss program that includes access to concierge on-demand wellness specialists: nutritionists, fitness experts, and personal support from behavioral experts, please visit www.uncraverx.com for more information on UnCraveRx®. The Company also controls BioCorRx Pharmaceuticals Inc., a clinical-stage drug development subsidiary currently seeking FDA approval for BICX104, an implantable naltrexone pellet for the treatment of alcohol and opioid use disorders. For more information on BICX and its subsidiary pipeline, please visit www. BioCorRx.com.
In the news
No coverage from other publishers is available.
Recent filings
10-Q filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
10-Q filing
10-Q filing
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities
Items 1.01, 3.02, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 7,533,473Source | 643,570Source | 1,907,459Source | 6,680,879Source | 478,535Source | 2,324,865Source | — | 317,444Source | 2,147,212Source | 385,941Source | 388,887Source | 766,594Source |
| Property, Plant and Equipment, NetUSD | 7,685Source | 31,685Source | 0Source | 11,083Source | 38,105Source | 1,452Source | — | 44,524Source | 4,062Source | 18,977Source | 50,943Source | 76,572Source |
| GoodwillUSD | 2,840,400Source | — | 563,158Source | 2,840,400Source | — | 563,158Source | — | — | 563,158Source | — | — | — |
| Current assets: | ||||||||||||
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 194,442Source | 0Source | 67,694Source | 51,242Source | 0Source | 330,348Source | — | 0Source | 253,459Source | 0Source | 740Source | 35,378Source |
| Inventory, NetUSD | 155,367Source | — | 43,551Source | 133,597Source | — | 143,425Source | — | — | 143,425Source | — | — | — |
| Assets, CurrentUSD | 1,462,176Source | 353,097Source | 623,377Source | 527,483Source | 172,010Source | 1,020,214Source | — | 151,593Source | 814,468Source | 117,996Source | 187,119Source | 316,910Source |
| Operating Lease, Right-of-Use AssetUSD | 169,443Source | 208,709Source | 137,869Source | 179,555Source | 218,046Source | 148,604Source | — | 70,658Source | 159,128Source | 199,184Source | 97,278Source | 270,406Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 20,297,768Source | 12,646,789Source | 14,379,077Source | 19,694,108Source | 11,626,131Source | 13,948,134Source | — | 11,185,587Source | 13,674,200Source | 12,741,173Source | 10,341,411Source | 8,968,325Source |
| Commitments and ContingenciesUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 20,188Source | 11,212Source | 29,666Source | 17,282Source | 9,783Source | 28,906Source | — | 8,897Source | 24,489Source | 13,299Source | 8,674Source | 7,719Source |
| Additional Paid in CapitalUSD | 73,575,400Source | 70,080,274Source | 76,183,780Source | 72,520,867Source | 69,424,316Source | 75,879,983Source | — | 68,470,650Source | 75,279,624Source | 70,953,807Source | 68,149,029Source | 66,130,296Source |
| Retained Earnings (Accumulated Deficit)USD | -87,201,843Source | -82,044,527Source | -88,559,898Source | -85,283,967Source | -80,557,140Source | -87,480,515Source | — | -79,339,794Source | -86,649,288Source | -83,209,142Source | -78,103,018Source | -74,336,105Source |
| Stockholders' Equity Attributable to ParentUSD | -13,484,639Source | -11,831,425Source | -12,224,836Source | -12,624,202Source | -11,001,425Source | -11,450,010Source | — | -10,738,622Source | -11,223,559Source | -12,120,420Source | -9,823,690Source | -8,201,731Source |
| Liabilities and EquityUSD | 7,533,473Source | 643,570Source | 1,907,459Source | 6,680,879Source | 478,535Source | 2,324,865Source | — | 317,444Source | 2,147,212Source | 385,941Source | 388,887Source | 766,594Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 15,038,127Source | 8,224,325Source | 8,854,703Source | 14,559,126Source | 7,314,968Source | 8,526,966Source | — | 7,168,130Source | 8,306,199Source | 8,207,615Source | 6,431,209Source | 5,363,792Source |
| Operating Lease, Liability, CurrentUSD | 41,686Source | 39,266Source | 45,146Source | 41,686Source | 38,491Source | 44,255Source | — | 104,062Source | 43,382Source | 40,057Source | 122,732Source | 134,343Source |
| Accounts Payable, CurrentUSD | 6,725,664Source | 3,096,150Source | 4,439,572Source | 3,705,309Source | 2,830,043Source | 4,355,149Source | — | 2,773,188Source | 4,028,744Source | 3,023,517Source | 2,473,457Source | 2,013,250Source |
| Operating Lease, Liability, NoncurrentUSD | 127,757Source | 169,443Source | 92,723Source | 137,869Source | 179,555Source | 104,349Source | — | 0Source | 115,745Source | 159,127Source | 10,945Source | 181,328Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 720,344Source | -171,794Source | -246,782Source | -389,027Source | -146,171Source | -173,259Source | -245,169Source | -129,521Source | -303,429Source | -234,812Source | -128,834Source | -125,257Source |
| Additional Financial Items | ||||||||||||
| Deferred Revenue, CurrentUSD | 56,590Source | — | 1,040Source | 56,590Source | — | — | — | — | 0Source | — | 0Source | 33,256Source |
| Deferred Revenue, NoncurrentUSD | — | 0Source | — | — | 0Source | — | — | 4,045Source | — | 0Source | 4,045Source | 4,045Source |
| Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Preferred Stock, Value, Issued | —Source | — | — | — | — | — | — | — | — | — | — | — |
| Accrued Liabilities, Current | — | — | —Source | — | — | — | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -808,502Source | -1,513,010Source | -1,001,706Source | -1,377,276Source | -859,892Source | -851,764Source | -3,508,763Source | -5,212,102Source | -3,770,490Source | 4,376,832Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | 71,986Source | 6,714Source | 9,834Source | 71,977Source | 11,195Source | 24,843Source | 44,003Source | 33,145Source | 26,808Source | 27,450Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 108,375Source | 151,257Source | 592,604Source | — | 277,055Source | 354,509Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 76,889Source | 111,966Source | 253,459Source | -740Source | -34,638Source | 33,878Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | — | — | 9,828Source | — | — | — |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -432,971Source | -689,623Source | -2,298,291Source | -1,096,254Source | -1,853,282Source | -2,041,773Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 505,522Source | 625,732Source | 2,349,618Source | 1,119,065Source | 1,849,889Source | 2,024,550Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 287,688Source | 90Source | 21,237Source | 111,872Source | 211,911Source | 24,142Source | 139,360Source | 88,033Source | 65,222Source | 68,615Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 707Source | 722Source | 521,358Source | 10,731Source | 17,188Source | 0Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Additional Financial Items | ||||||||||||
| AmortizationUSD | — | — | 121,774Source | 121,774Source | — | 118,554Source | 115,334Source | 115,334Source | 477,436Source | 480,656Source | 477,436Source | 477,436Source |
| Share-based Payment Arrangement, ExpenseUSD | — | — | 16,060Source | 29,261Source | 0Source | 0Source | 0Source | 35,099Source | 112,009Source | 229,599Source | 63,941Source | 111,079Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | 0Source | 51,198Source | 55,738Source | — | — | — |
| DepreciationUSD | — | — | 1,474Source | 6,420Source | 1,452Source | 4,130Source | 2,610Source | 3,764Source | 14,915Source | 31,966Source | 25,629Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | 0Source | -123,563Source | -47,000Source | -55,000Source | -100,000Source | -132,514Source | -187,514Source | -164,602Source | -34,338Source | 133,424Source |
| GoodwillUSD | — | — | 2,840,400Source | — | 563,158Source | 2,840,400Source | 563,158Source | — | 563,158Source | — | — | — |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | — | 0Source | 0Source | 0Source | 6,374Source | 0Source | — | 0Source | 47,980Source | 0Source |
| Income Tax Expense (Benefit)USD | — | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,917,873Source | -1,487,387Source | -964,774Source | -1,233,418Source | -831,227Source | -841,407Source | -3,440,146Source | -5,212,102Source | -3,770,490Source | -4,376,832Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -1,109,371Source | 25,623Source | -36,932Source | -143,858Source | -28,665Source | -10,357Source | -68,617Source | — | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | -5,106,124Source | — | — |
| Nonoperating Income (Expense)USD | — | — | 1,137,085Source | 146,711Source | 463,832Source | 36,644Source | 96,108Source | 86,182Source | 1,322,879Source | -89,597Source | 17,306Source | — |
| Operating ExpensesUSD | — | — | 2,580,811Source | 1,659,721Source | 1,553,508Source | 1,592,158Source | 1,170,539Source | 1,072,845Source | 5,628,886Source | 5,130,170Source | 3,876,956Source | 4,911,836Source |
| Operating Lease, ExpenseUSD | — | — | 13,636Source | 13,636Source | 13,636Source | 13,636Source | 13,636Source | 13,636Source | 54,544Source | 74,708Source | 138,932Source | 144,978Source |
| Other Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | — | — | — | — | 321,163Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | 700,000Source | — | — | — | 1,250,000Source |
| Goodwill, Impairment Loss | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Operating Lease, Lease Income | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Other Depreciation and Amortization | — | — | — | —Source | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 635,224Source | 0Source | 87,970Source | 178,238Source | 214,539Source | 134,899Source | 797,244Source | 7,665Source | 89,160Source | 213,841Source |
| Cost of RevenueUSD | — | — | — | 0Source | 144,967Source | 0Source | 25,184Source | 0Source | — | 1,667Source | 35,986Source | 18,946Source |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | — | — | 1,145,353Source | 1,192,869Source | 686,323Source | 1,223,321Source | 775,453Source | 886,083Source | 3,794,126Source | 3,612,481Source | 2,875,119Source | 3,409,649Source |
| Operating Income (Loss)USD | — | — | -1,945,587Source | -1,659,721Source | -1,465,538Source | -1,413,920Source | -956,000Source | -937,946Source | -4,831,642Source | -5,122,505Source | -3,787,796Source | -4,697,995Source |
| Other Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | — | — | — | — | 321,163Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -808,502Source | -1,513,010Source | -1,001,706Source | -1,377,276Source | -859,892Source | -851,764Source | -3,508,763Source | -5,212,102Source | -3,770,490Source | -4,376,832Source |
| Income Tax Expense (Benefit)USD | — | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -1,109,371Source | 25,623Source | -36,932Source | -143,858Source | -28,665Source | -10,357Source | -68,617Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,917,873Source | -1,487,387Source | -964,774Source | -1,233,418Source | -831,227Source | -841,407Source | -3,440,146Source | -5,212,102Source | -3,770,490Source | -4,376,832Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.11Source | -0.14Source | -0.03Source | -0.07Source | -0.03Source | -0.06Source | -0.19Source | — | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 18,162,783Source | 10,908,291Source | 29,219,541Source | 17,011,680Source | 25,599,642Source | 15,094,736Source | 18,485,888Source | 3,378,376Source | 2,697,299Source | 1,447,913Source |
| Additional Financial Items | ||||||||||||
| Business Combination, Acquisition Related CostsUSD | — | — | — | — | — | — | — | — | 528,622Source | — | — | — |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 71,986Source | 6,714Source | 9,834Source | 71,977Source | 11,195Source | 24,843Source | 44,003Source | 33,145Source | 26,808Source | 27,450Source |
| Income (Loss) Attributable to Parent, before TaxUSD | — | — | — | — | — | — | — | — | — | — | -3,766,913Source | -4,369,413Source |
| Interest ExpenseUSD | — | — | 29,672Source | 148,999Source | 30,048Source | 36,686Source | 31,041Source | 87,483Source | 223,850Source | 776,780Source | 194,041Source | 150,969Source |
| Interest Expense, DebtUSD | — | — | 193,431Source | 148,999Source | 30,048Source | 36,563Source | 31,041Source | 87,483Source | 223,850Source | — | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | -5,106,124Source | — | — |
| Nonoperating Income (Expense)USD | — | — | 1,137,085Source | 146,711Source | 463,832Source | 36,644Source | 96,108Source | 86,182Source | 1,322,879Source | -89,597Source | 17,306Source | — |
| Operating ExpensesUSD | — | — | 2,580,811Source | 1,659,721Source | 1,553,508Source | 1,592,158Source | 1,170,539Source | 1,072,845Source | 5,628,886Source | 5,130,170Source | 3,876,956Source | 4,911,836Source |
| Operating Lease, ExpenseUSD | — | — | 13,636Source | 13,636Source | 13,636Source | 13,636Source | 13,636Source | 13,636Source | 54,544Source | 74,708Source | 138,932Source | 144,978Source |
| Other IncomeUSD | — | — | — | — | — | — | — | — | 0Source | 32,405Source | — | 139,381Source |
| Research and Development ExpenseUSD | — | — | 1,004,660Source | 460,138Source | 712,384Source | 296,860Source | 352,333Source | 161,919Source | 1,768,955Source | 1,482,877Source | 891,063Source | 1,459,458Source |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | — | —Source | — | — | — | — | — | — |
| Goodwill, Impairment Loss | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Marketing and Advertising Expense | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
| Operating Lease, Lease Income | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
Filing attachments
bicx_ex41.htm · 8-K · 2025-08-01
EX-4.1 2 bicx_ex41.htm FORM OF WARRANT bicx_ex41.htm EXHIBIT 4.1 THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES M…
Read attachment ↗bicx_ex41.htm · 8-K · 2025-03-11
EX-4.1 2 bicx_ex41.htm FORM OF WARRANT bicx_ex41.htm EXHIBIT 4.1 THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES M…
Read attachment ↗bicx_ex991.htm · 8-K · 2025-03-11
EX-99.1 5 bicx_ex991.htm PRESS RELEASE bicx_ex991.htm EXHIBIT 99.1 BioCorRx Pharmaceuticals Inc. announces that it has acquired LUCEMYRA® (lofexidine), an FDA-Approved Opioid Withdrawal Medication, from USWM, LLC ANAHEIM, CA & Louisville, KY, March 10, 2025 - BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders and USWM LLC, a specialty pharmaceutical company dedicated to addressing unmet medical n…
Read attachment ↗